Development of an in vivo delivery system for CRISPR/Cas9-mediated targeting of hepatitis B virus cccDNA
Mohammad Enamul Hoque Kayesh(Kagoshima University), Kyoko Tsukiyama–Kohara(Kumamoto University), Michinori Kohara(Tokyo Metropolitan Institute of Medical Science), Tatsuro Hifumi(Kagoshima University), Masaya Sugiyama(National Center for Global Health and Medicine), Md Abul Hashem(Kagoshima University), Yutaka Amako, Noriaki Miyoshi(Kagoshima University), Shuko Murakami(Nagoya City University), Naoki Yamamoto(Tokyo Metropolitan Institute of Medical Science), Masashi Mizokami(National Center for Global Health and Medicine), Shintaro Ogawa(Nagoya City University), Yasuhito Tanaka(Nagoya City University)
Cited by 35
Related Papers
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan
|Hepatology|2001|418
A Case–Control Study for Clinical and Molecular Biological Differences Between Hepatitis B Viruses of Genotypes B and C
|Hepatology|2001|396
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study
|Clinical Infectious Diseases|2015|149
Sustainable Antibiotic-Free Broiler Meat Production: Current Trends, Challenges, and Possibilities in a Developing Country Perspective
|Biology|2020|141
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels
|Journal of Hepatology|2022|121